Novel Rx
4 years ago
Based on RECIPE, how many of you will use MMF concomitantly with start of pegloticase in treating refractory gout patients? #ACR20 @RheumNow
Combo Therapy v Monotherapy (SEAM-RA Trial): Dr. Richard Conway
Dr. Conway discusses ACR abstract #0939 presented Saturday at the 2020 ACR annual meeting.
Treatment of Dermatomyositis Studies: Dr Robert Chao
Dr. Robert Chao reviews two important abstracts - #0955 (IVIg) and #0958 (tocilizumab) - on the treatment of dermatomyositis as presented at the 2020 ACR annual meeting.
4 years ago
Dr Khanna presents RECIPE RCT of MMF to reduce immunogenicity of pegloticase. Sustained urate response ≤6mg/dL at 24 weeks 68% with MMF compared to 30% in placebo. @rheumnow #ACR20 Abstr#952 #ACRbest https://t.co/64nN5AqK3W
What is the SEAMless transition from combination Etanercept to Methotrexate? Dr. Jonathan Kay
Dr. Jonathan Kay takes a deep dive into plenary abstract #0939 presented at the ACR 2020 annual meeting, reviewing two previous clinical trials that also looked at this question and offering his perspective.
Staying on Therapy in RA: Dr. Janet Pope
Dr. Janet Pope reviews abstract #0804 - Factors That Influence Biological Survival in Rheumatoid Arthritis: Results of a Real-world Cohort from the Netherlands- presented at the ACR 2020 annual meeting.
Pegloticase, a mammalian PEGylated recombinant uricase is approved for chronic refractory gout treatment. It decreases the serum uric acid and the signs and symptoms of gout. High titer anti-drug…
4 years ago
Today's #ACR20 lecture @r_burmester shows the biologic revolution was a result of serendipity -- this will spark the long-awaited new & improved name of our profession: serendipitology! Hi I'm Dr. Worthing I'm a Serendipitologist. I use drugs intended for infections, cancer etc.! https://t.co/buDqwAVK9u
Combination therapy with biologic and conventional DMARDs can be highly effective at inducing remission in patients with rheumatoid arthritis. Once controlled under therapy, patients are often very…
4 years ago
After the SEAM-RA study, in patients taking MTX and ETN in sustained remission would you? #ACR20 @rheumnow
Poster Hall